Markwin Maring
Chief Executive Officer bij CANNONAU CORP.
Oorsprong van het eerstegraads netwerk van Markwin Maring
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
United Telecom NV
United Telecom NV Specialty TelecommunicationsCommunications United Telecom NV develops software technologies for mobile operators. It provides fixed and mobile telephony and VDSL products. The company was founded in 1990 and is headquartered in Rotselaar, Belgium.
3
| Subsidiary | Specialty Telecommunications | 3 |
Concordia Capital Netherlands BV
Concordia Capital Netherlands BV Investment ManagersFinance Concordia Capital Netherlands BV is a Private Equity/Venture Capital firm, a subsidiary of Concordia Management BV founded in 2001 by Markwin H. Maring. The firm is headquartered in Rotterdam.
1
| Subsidiary | Investment Managers | 1 |
Public Company | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Markwin Maring via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
PETRO USA, INC. | Specialty Stores | Director of Finance/CFO | |
NEW YOU, INC. | Household/Personal Care | Chairman | |
CF Management Rotterdam BV
CF Management Rotterdam BV Investment ManagersFinance CF Management Rotterdam (CF) is the private equity subsidiary of Filonie Management Services BV in The Netherlands. Formerly known as Concordia Management, the firm is based in The Hague and invests and advises private equity funds, namely MeesPierson Informal Opportunity Fund BV (MPF) and Concordia Fund BV (CF). | Investment Managers | Private Equity Investor | |
DSM Venturing BV
DSM Venturing BV Investment ManagersFinance DSM Venturing BV (DSM Venturing) is the venture capital arm of Royal DSM NV in the Netherlands founded in 2001. DSM Venturing BV is headquartered in Geleen. | Investment Managers | Private Equity Investor | |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
ACS Biomarker BV
ACS Biomarker BV Medical SpecialtiesHealth Technology ACS Biomarker BV develops and commercializes cardiovascular biomarkers. The firm offers miRNA profiling services. It engages in the discovery, validation, and commercialization of biomarkers that improve diagnosis, prognosis and management of cardiac diseases. The company was founded in 2007 by Mat J. A. P. Daemen, Yigal M. Pinto and Tilman Hackeng and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Director/Board Member | |
FABPulous BV
FABPulous BV Medical SpecialtiesHealth Technology FABPulous BV develops a handheld disposable plasma separation device with embedded in vitro diagnostic test capability. It offers ultra rapid plasma preparation platform that can make a defined dilution of plasma from a small volume of whole blood in seconds and integrated lateral flow IVD platform. The company’s tests provide diagnosis and benefit to the patient, as well as the healthcare sector, the insurance industry, governments and society in general. FABPulous was founded in 2008 and is headquartered in Maastricht, the Netherlands. | Medical Specialties | Director/Board Member | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Brightlands Venture Partners BV
Brightlands Venture Partners BV Investment ManagersFinance Brightlands Venture Partners is an independent regional venture capital firm headquartered in Brightlands, Netherlands. The firm was founded in 2004. | Investment Managers | Private Equity Investor | |
Aquamarine Holdings LLC | President | ||
Neuroplast BV
Neuroplast BV BiotechnologyHealth Technology Neuroplast BV is a Dutch stem cell technology company that focuses on developing autologous cell products for the treatment of primarily inflammation-driven neurological disorders. Neuroplast is located in Brightlands Chemelot Campus in the Netherlands. The company's transformative treatment, Neuro-cellsò, is currently being tested for traumatic spinal cord injury (TSCI) and aims to reduce the irreversible impact of TSCI during the crucial first phase. The company was founded in August 2014 by physician De Munter and neurologist Erik Wolters, and current investors include Invest, Brightlands Venture Partners, and Liof NV. Johannes de Munter has been the CEO of the company since 2016. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Nederland | 10 |
Verenigde Staten | 4 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 7 |
Finance | 5 |
Retail Trade | 2 |
Consumer Non-Durables | 2 |
Operationeel
Director/Board Member | 11 |
Private Equity Investor | 5 |
Director of Finance/CFO | 3 |
President | 3 |
Corporate Secretary | 2 |
Sterkste connecties
- Beurs
- Insiders
- Markwin Maring
- Bedrijfsconnecties